2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 7, 2012, Pages 1023-1082

  Holmes Jr , David R ^a   Mack, Michael J ^a   Kaul, Sanjay ^a   Agnihotri, Arvind ^a   Alexander, Karen P ^a   Bailey, Steven R ^a   Calhoon, John H ^a   Carabello, Blase A ^a   Desai, Milind Y ^a   Edwards, Fred H ^a   Francis, Gary S ^a   Gardner, Timothy J ^a   Kappetein, A Pieter ^a   Linderbaum, Jane A ^a   Mukherjee, Chirojit ^a   Mukherjee, Debabrata ^a   Otto, Catherine M ^a   Ruiz, Carlos E ^a   Sacco, Ralph L ^a   Smith, Donnette ^a   Thomas, James D ^a   more..

^a NONE

Author keywords

ACCF clinical expert consensus document; Aortic stenosis; Aortic valve replacement; Heart team; High risk patients; Percutaneous valve therapy; Structural heart disease; Transcatheter aortic valve implantation; Transcatheter aortic valve replacement

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; THROMBIN INHIBITOR; WARFARIN;

ANESTHESIA INDUCTION; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; AORTIC VALVE REPAIR; BALLOON DILATATION; BRAIN HEMORRHAGE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOLOGIST; CARDIOPULMONARY BYPASS; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR MAGNETIC RESONANCE; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; CORONARY ARTERY DISEASE; DEVICE MIGRATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE REGISTRY; DISEASE SEVERITY; DRUG CHOICE; ELDERLY CARE; EXERCISE TEST; FORWARD HEART FAILURE; FRAIL ELDERLY; GUIDE WIRE; HEART ATRIUM FIBRILLATION; HEART BLOCK; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VALVE BIOPROSTHESIS; HIGH RISK PATIENT; HIGH RISK POPULATION; HOSPITAL READMISSION; HUMAN; IATROGENIC DISEASE; INFORMED CONSENT; INTERNATIONAL NORMALIZED RATIO; INTRAOPERATIVE PERIOD; LEARNING CURVE; LONG TERM CARE; MITRAL VALVE REGURGITATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PATIENT CARE PLANNING; PATIENT DECISION MAKING; PATIENT SAFETY; PATIENT SELECTION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PULMONARY HYPERTENSION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SHOCK; STROKE; SURGEON; SURGICAL RISK; SURGICAL TECHNOLOGY; SURVIVAL RATE; THREE DIMENSIONAL ECHOCARDIOGRAPHY; THROMBOEMBOLISM; THROMBOSIS; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSLUMINAL VALVULOPLASTY; TRICUSPID VALVE REGURGITATION; VASCULAR ACCESS; VASCULAR DISEASE;

AORTIC VALVE STENOSIS; EVIDENCE-BASED MEDICINE; HEART CATHETERIZATION; HEART FUNCTION TESTS; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; REGISTRIES; TREATMENT OUTCOME;

EID: 84861992992     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24351     Document Type: Conference Paper

References (260)

1. Holmes DR Jr., Mack MJ. Transcatheter valve therapy a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58:445-455.
2. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111:920-925. (Pubitemid 40279895)
3. Selzer A. Changing aspects of the natural history of valvular aortic stenosis. N Engl J Med. 1987;317:91-98. (Pubitemid 17093738)
4. Stephan PJ, Henry AC III, Hebeler RF Jr., et al. Comparison of age, gender, number of aortic valve cusps, concomitant coronary artery bypass grafting, and magnitude of left ventricular-systemic arterial peak systolic gradient in adults having aortic valve replacement for isolated aortic valve stenosis. Am J Cardiol. 1997;79:166-172. (Pubitemid 127673704)
5. Ghaisas NK, Foley JB, O'Briain DS, et al. Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement. J Am Coll Cardiol. 2000;36:2257-2262.
6. Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90:844-853. (Pubitemid 24242754)
7. Peterson KL, Tsuji J, Johnson A, et al. Diastolic left ventricular pressure-volume and stress-strain relations in patients with valvular aortic stenosis and left ventricular hypertrophy. Circulation. 1978;58:77-89. (Pubitemid 8376663)
8. Spann JF, Bove AA, Natarajan G, et al. Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis. Circulation. 1980;62:576-582. (Pubitemid 10059071)
9. Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009;373: 956-966.
10. Marcus ML, Doty DB, Hiratzka LF, et al. Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. N Engl J Med. 1982;307:1362-1366. (Pubitemid 13233012)
11. Koyanagi S, Eastham CL, Harrison DG, et al. Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy. Circ Res. 1982;50:55-62. (Pubitemid 12209536)
12. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation. 1979;59:679-688. (Pubitemid 9154960)
13. Krayenbuehl HP, Hess OM, Ritter M, et al. Left ventricular systolic function in aortic stenosis. Eur Heart J. 1988;9 Suppl E:19-23.
14. Carabello BA, Green LH, Grossman W, et al. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation. 1980;62:42-48. (Pubitemid 10083095)
15. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
16. Gardin JM, Kaplan KJ, Meyers SN, et al. Aortic stenosis: can severity be reliably estimated noninvasively? Chest. 1980;77: 130-131. (Pubitemid 10164240)
17. Morrow AG, Roberts WC, Ross J Jr., et al. Obstruction to left ventricular outflow. Current concepts of management and operative treatment. Ann Intern Med. 1968;69:1255-1286.
18. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22:1-23.
19. Popovic AD, Thomas JD, Neskovic AN, et al. Time-related trends in the preoperative evaluation of patients with valvular stenosis. Am J Cardiol. 1997;80:1464-1468. (Pubitemid 27523028)
20. Blais C, Burwash IG, Mundigler G, et al. Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation. 2006;113:711-721.
21. Grayburn PA. Assessment of low-gradient aortic stenosis with dobutamine. Circulation. 2006;113:604-606.
22. Monin JL, Monchi M, Gest V, et al. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography. J Am Coll Cardiol. 2001;37:2101-2107. (Pubitemid 32548004)
23. Nishimura RA, Grantham JA, Connolly HM, et al. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation. 2002;106:809-813.
24. Shanewise JS, Cheung AT, Aronson S, et al. ASE/SCA guidelines for performing a comprehensive intraoperative multiplane transesophageal echocardiography examination: recommendations of the American Society of Echocardiography Council for Intraoperative Echocardiography and the Society of Cardiovascular Anesthesiologists Task Force for Certification in Perioperative Transesophageal Echocardiography. Anesth Analg. 1999;89:870-884. (Pubitemid 29458571)
25. Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). J Am Coll Cardiol. 2007;49:378-402. (Pubitemid 46099075)
26. Hundley WG, Bluemke DA, Finn JP, et al. ACCF/ACR/AHA/ NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010;55:2614-2662.
27. Lancellotti P, Lebois F, Simon M, et al. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation. 2005;112:I377-I382. (Pubitemid 41266702)
28. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). J Am Coll Cardiol. 2008;52:e1-e142.
29. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-268. (Pubitemid 46276943)
30. Connolly HM, Oh JK, Orszulak TA, et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators. Circulation. 1997;95:2395-2400. (Pubitemid 27224734)
31. Kvidal P, Bergstrom R, Horte LG, et al. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. 2000;35:747-756. (Pubitemid 30167033)
32. Kolh P, Kerzmann A, Honore C, et al. Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur J Cardiothorac Surg. 2007;31:600-606. (Pubitemid 46400496)
33. Litmathe J, Feindt P, Kurt M, et al. Aortic valve replacement in octogenarians: outcome and predictors of complications. Hellenic J Cardiol. 2011;52:211-215.
34. Pereira JJ, Balaban K, Lauer MS, et al. Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery. Am J Med. 2005;118:735-742. (Pubitemid 40897659)
35. Smith WT, Ferguson TB Jr., Ryan T, et al. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J Am Coll Cardiol. 2004;44:1241-1247. (Pubitemid 39208879)
36. Adams DH, Chikwe J, Filsoufi F, et al. The year in cardiovascular surgery. J Am Coll Cardiol. 2011;57:1425-1444.
37. Byrne JG, Leacche M, Unic D, et al. Staged initial percutaneous coronary intervention followed by valve surgery ("hybrid approach") for patients with complex coronary and valve disease. J Am Coll Cardiol. 2005;45:14-18. (Pubitemid 40052019)
38. He GW, Acuff TE, Ryan WH, et al. Aortic valve replacement: determinants of operative mortality. Ann Thorac Surg. 1994;57:1140-1146. (Pubitemid 24204495)
39. Pai RG, Varadarajan P, Kapoor N, et al. Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. Ann Thorac Surg. 2007;84:80-85. (Pubitemid 46921129)
40. Kapoor N, Varadarajan P, Pai RG. Echocardiographic predictors of pulmonary hypertension in patients with severe aortic stenosis. Eur J Echocardiogr. 2008;9:31-33. (Pubitemid 351664800)
41. McHenry MM, Rice J, Matlof HJ, et al. Pulmonary hypertension and sudden death in aortic stenosis. Br Heart J. 1979;41:463-467. (Pubitemid 9180371)
42. Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080-1090.
43. Ben-Dor I, Goldstein SA, Pichard AD, et al. Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis. Am J Cardiol. 2011;107:1046-1051.
44. Cam A, Goel SS, Agarwal S, et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis. J Thorac Cardiovasc Surg. 2011;142:800-808.
45. Khandhar S, Varadarajan P, Turk R, et al. Survival benefit of aortic valve replacement in patients with severe aortic regurgitation and pulmonary hypertension. Ann Thorac Surg. 2009;88:752-756.
46. Zuern CS, Eick C, Rizas K, et al. Prognostic value of mild-to-moderate pulmonary hypertension in patients with severe aortic valve stenosis undergoing aortic valve replacement. Clin Res Cardiol. 2012;101:81-88.
47. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association. J Am Coll Cardiol. 2009;53:1573-1619.
48. Santini F, Casali G, Franchi G, et al. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults. Int J Cardiol. 2005;103:156-163. (Pubitemid 41096028)
49. Fattouch K, Sbraga F, Bianco G, et al. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement. J Card Surg. 2005;20:171-176. (Pubitemid 40460131)
50. Trachte AL, Lobato EB, Urdaneta F, et al. Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Ann Thorac Surg. 2005;79:194-197. (Pubitemid 40037471)
51. Huber D, Grimm J, Koch R, et al. Determinants of ejection performance in aortic stenosis. Circulation. 1981;64:126-134. (Pubitemid 11056469)
52. Herrmann S, Stork S, Niemann M, et al. Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. J Am Coll Cardiol. 2011;58:402-412.
53. Tribouilloy C, Levy F, Rusinaru D, et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol. 2009;53:1865-1873.
54. Quere JP, Monin JL, Levy F, et al. Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation. 2006;113:1738-1744. (Pubitemid 43958466)
55. Kolh P, Wijns W, Danchin N, et al. Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2010;38Suppl:S1-52.
56. Toole JM, Stroud MR, Kratz JM, et al. Twenty-five year experience with the St. Jude medical mechanical valve prosthesis. Ann Thorac Surg. 2010;89:1402-1409.
57. Braunwald E. Aortic valve replacement: an update at the turn of the millennium. Eur Heart J. 2000;21:1032-1033. (Pubitemid 30352982)
58. Nashef SA, Roques F, Hammill BG, et al. Validation of European System for Cardiac Operative Risk Evaluation (Euro- SCORE) in North American cardiac surgery. Eur J Cardiothorac Surg. 2002;22:101-105.
59. Shroyer AL, Coombs LP, Peterson ED, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75:1856-1864.
60. Society of Thoracic Surgeons national cardiac surgery database. Available at: http://www.sts.org/national-database. Accessed January 13, 2012.
61. O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg. 2009;88:S23-S42.
62. Thourani VH, Ailawadi G, Szeto WY, et al. Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study. Ann Thorac Surg. 2011;91:49-55.
63. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). J Am Coll Cardiol. 2006;48:e1-e148. (Pubitemid 44109952)
64. Melby SJ, Moon MR, Lindman BR, et al. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg. 2011;141:1424-1430.
65. Sundermann S, Dademasch A, Praetorius J, et al. Comprehensive assessment of frailty for elderly high-risk patients undergoing cardiac surgery. Eur J Cardiothorac Surg. 2011;39:33-37.
66. Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol. 1995;25:1111-1119.
67. Brown JM, O'Brien SM, Wu C, et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009;137:82-90.
68. Bloomfield P, Wheatley DJ, Prescott RJ, et al. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med. 1991;324:573-579.
69. Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:517-584.
70. Ferrari E, Tozzi P, Hurni M, et al. Primary isolated aortic valve surgery in octogenarians. Eur J Cardiothorac Surg. 2010;38:128-133.
71. Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol. 2007;50:2018-2019. (Pubitemid 350046335)
72. Bach DS, Siao D, Girard SE, et al. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes. 2009;2:533-539.
73. Dua A, Dang P, Shaker R, et al. Barriers to surgery in severe aortic stenosis patients with Class I indications for aortic valve replacement. J Heart Valve Dis. 2011;20:396-400.
74. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231-1243. (Pubitemid 36834640)
75. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?. Eur Heart J. 2005;26:2714-2720. (Pubitemid 41746694)
76. Varadarajan P, Kapoor N, Bansal RC, et al. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg. 2006;82:2111-2115.
77. Bouma BJ, van Der Meulen JH, van Den Brink RB, et al. Variability in treatment advice for elderly patients with aortic stenosis: a nationwide survey in the Netherlands. Heart. 2001;85:196-201. (Pubitemid 32973593)
78. Varadarajan P, Kapoor N, Bansal RC, et al. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: results from a cohort of 277 patients aged > or =80 years. Eur J Cardiothorac Surg. 2006;30:722-727. (Pubitemid 44574533)
79. Mihaljevic T, Nowicki ER, Rajeswaran J, et al. Survival after valve replacement for aortic stenosis: implications for decision making. J Thorac Cardiovasc Surg. 2008;135:1270-1278.
80. Gammie JS, Brown JW, Brown JM, et al. Aortic valve bypass for the high-risk patient with aortic stenosis. Ann Thorac Surg. 2006;81:1605-1610. (Pubitemid 350030009)
81. Palta S, Pai AM, Gill KS, et al. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation. 2000;101:2497-2502. (Pubitemid 30366254)
82. Rajamannan NM, Otto CM. Targeted therapy to prevent progression of calcific aortic stenosis. Circulation. 2004;110: 1180-1182. (Pubitemid 39202329)
83. Cribier A, Savin T, Saoudi N, et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement?. Lancet. 1986;1:63-67.
84. Ben-Dor I, Pichard AD, Satler LF, et al. Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients. J Am Coll Cardiol Intv. 2010;3:1150-1156.
85. Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol. 1995;26:1522-1528.
86. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation. 1994;89:642-650. (Pubitemid 24056191)
87. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation. 1991;84:2383-2397.
88. Ben-Dor I, Maluenda G, Looser PM, et al. Outcomes of concomitant percutaneous coronary intervention and balloon aortic valvuloplasty. Catheter Cardiovasc Interv. 2011: published online before print July 6, 2011, doi:10.1002/ccd.23193. Accessed January 13, 2012.
89. Hara H, Pedersen WR, Ladich E, et al. Percutaneous balloon aortic valvuloplasty revisited: time for a renaissance?. Circulation. 2007;115:e334-e338. (Pubitemid 46648656)
90. Ussia GP, Capodanno D, Barbanti M, et al. Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation. J Invasive Cardiol. 2010;22:161-166.
91. Chiam PT, Ruiz CE. Percutaneous transcatheter aortic valve implantation: assessing results, judging outcomes, and planning trials: the interventionalist perspective. J Am Coll Cardiol Intv. 2008;1:341-350.
92. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves: description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J. 1992;13:704-708.
93. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006-3008. (Pubitemid 35440280)
94. Chiam PT, Ruiz CE. Percutaneous transcatheter aortic valve implantation: evolution of the technology. Am Heart J. 2009;157:229-242.
95. Dalmau MJ, Gonzalez-Santos JM, Blazquez JA, et al. Hemodynamic performance of the Medtronic Mosaic and Perimount Magna aortic bioprostheses: five-year results of a prospectively randomized study. Eur J Cardiothorac Surg. 2011;39:844-852.
96. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57:253-269.
97. Avanzas P, Munoz-Garcia AJ, Segura J, et al. Percutaneous implantation of the CoreValve self-expanding aortic valve prosthesis in patients with severe aortic stenosis: early experience in Spain. Rev Esp Cardiol. 2010;63:141-148.
98. Deleted in proof.
99. Deleted in proof.
100. Deleted in proof.
101. Deleted in proof.
102. Deleted in proof.
103. Deleted in proof.
104. Deleted in proof.
105. Buellesfeld L, Gerckens U, Schuler G, et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol. 2011;57:1650-1657.
106. Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32:191-197.
107. Godino C, Maisano F, Montorfano M, et al. Outcomes after transcatheter aortic valve implantation with both Edwards- SAPIEN and CoreValve devices in a single center: the Milan experience. J Am Coll Cardiol Intv. 2010;3:1110-1121.
108. Moynagh AM, Scott DJ, Baumbach A, et al. CoreValve transcatheter aortic valve implantation via the subclavian artery: comparison with the transfemoral approach. J Am Coll Cardiol. 2011;57:634-635.
109. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299-308.
110. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011;32:198-204.
111. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62-69.
112. di Marco F, Gerosa G. Percutaneous aortic valve replacement: which patients are suitable for it? A quest for a controlled use. J Thorac Cardiovasc Surg. 2007;133:294-298. (Pubitemid 46136280)
113. ElBardissi AW, Shekar P, Couper GS, et al. Minimally invasive aortic valve replacement in octogenarian, high-risk, trans-catheter aortic valve implantation candidates. J Thorac Cardiovasc Surg. 2011;141:328-335.
114. Higgins J, Ye J, Humphries KH, et al. Early clinical outcomes after transapical aortic valve implantation: a propensity-matched comparison with conventional aortic valve replacement. J Thorac Cardiovasc Surg. 2011;142:e47-e52.
115. Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) registry. J Am Coll Cardiol. 2011;58:2130-2138.
116. Lefevre T, Kappetein AP, Wolner E, et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J. 2011;32:148-157.
117. Krane M, Deutsch MA, Bleiziffer S, et al. Quality of life among patients undergoing transcatheter aortic valve implantation. Am Heart J. 2010;160:451-457.
118. Ussia GP, Mule M, Barbanti M, et al. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J. 2009;30:1790-1796.
119. Bekeredjian R, Krumsdorf U, Chorianopoulos E, et al. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age. Am J Cardiol. 2010;106:1777-1781.
120. Gotzmann M, Hehen T, Germing A, et al. Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis. Heart. 2010;96:1102-1106.
121. Wendler O, Walther T, Schroefel H, et al. The SOURCE registry: what is the learning curve in trans-apical aortic valve implantation? Eur J Cardiothorac Surg. 2011;39:853-859.
122. Reynolds MR, Magnuson EA, Lei Y, et al. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2011;124:1964-1972.
123. Cohen DJ. Health-related quality of life after transcatheter vs. surgical aortic valve replacement in high-risk patients with severe aortic stenosis. Results from the PARTNER trial (Cohort A). Presented at: TCT 2011; November 10, 2011; San Francisco, CA.
124. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198.
125. Rodes-Cabau J, Dumont E, Boone RH, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18-28.
126. Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121:870-878.
127. Arnold M, Schulz-Heise S, Achenbach S, et al. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. J Am Coll Cardiol Intv. 2010;3:1126-1132.
128. Ghanem A, Muller A, Nahle CP, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010;55:1427-1432.
129. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:227-276.
130. Gutsche JT, Cheung AT, McGarvey ML, et al. Risk factors for perioperative stroke after thoracic endovascular aortic repair. Ann Thorac Surg. 2007;84:1195-1200. (Pubitemid 47417888)
131. Bleiziffer S, Ruge H, Horer J, et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. J Am Coll Cardiol Intv. 2010;3:524-530.
132. Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. J Am Coll Cardiol Intv. 2008;1:310-316. (Pubitemid 351804194)
133. Koos R, Mahnken AH, Aktug O, et al. Electrocardiographic and imaging predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. J Heart Valve Dis. 2011;20:83-90.
134. Nuis RJ, Van Mieghem NM, Schultz CJ, et al. Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur Heart J. 2011;32:2067-2074.
135. D'Ancona G, Pasic M, Unbehaun A, et al. Permanent pace-maker implantation after transapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg. 2011;13:373-376.
136. Wenaweser P, Pilgrim T, Roth N, et al. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J. 2011;161:1114-1124.
137. Kahlert P, Al-Rashid F, Weber M, et al. Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz. 2009;34:398-408.
138. Hayashida K, Lefevre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. J Am Coll Cardiol Intv. 2011;4:851-858.
139. Kodali SK, O'Neill WW, Moses JW, et al. Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). Am J Cardiol. 2011;107:1058-1064.
140. Modine T, Obadia JF, Choukroun E, et al. Transcutaneous aortic valve implantation using the axillary/subclavian access: feasibility and early clinical outcomes. J Thorac Cardiovasc Surg. 2011;141:487-491, 491.
141. Nuis RJ, Piazza N, Van Mieghem NM, et al. In-hospital complications after transcatheter aortic valve implantation revisited according to the valve academic research consortium definitions. Catheter Cardiovasc Interv. 2011;78:457-467.
142. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-972.
143. Kempfert J, Van Linden A, Linke A, et al. Transapical aortic valve implantation: therapy of choice for patients with aortic stenosis and porcelain aorta? Ann Thorac Surg. 2010;90:1457-1461.
144. Douglas PS, Otto CM, Mickel MC, et al. Gender differences in left ventricle geometry and function in patients undergoing balloon dilatation of the aortic valve for isolated aortic stenosis. NHLBI Balloon Valvuloplasty Registry. Br Heart J. 1995;73:548-554.
145. Carroll JD, Carroll EP, Feldman T, et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation. 1992;86:1099-1107.
146. Aurigemma GP, Silver KH, McLaughlin M, et al. Impact of chamber geometry and gender on left ventricular systolic function in patients > 60 years of age with aortic stenosis. Am J Cardiol. 1994;74:794-798. (Pubitemid 24312973)
147. Legget ME, Kuusisto J, Healy NL, et al. Gender differences in left ventricular function at rest and with exercise in asymptomatic aortic stenosis. Am Heart J. 1996;131:94-100. (Pubitemid 26021370)
148. Villari B, Campbell SE, Schneider J, et al. Sex-dependent differences in left ventricular function and structure in chronic pressure overload. Eur Heart J. 1995;16:1410-1419.
149. Lunney JR, Lynn J, Foley DJ, et al. Patterns of functional decline at the end of life. JAMA. 2003;289:2387-2392. (Pubitemid 37430171)
150. Fried LP, Tangen CM, Walston J, et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156.
151. Himbert D, Descoutures F, Al-Attar N, et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol. 2009;54:303-311.
152. Afilalo J, Eisenberg MJ, Morin JF, et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol. 2010;56:1668-1676.
153. Consensus statement of the Society of Critical Care Medicine's Ethics Committee regarding futile and other possibly inadvisable treatments. Crit Care Med. 1997;25:887-891.
154. American Thoracic Society. Withholding and withdrawing life-sustaining therapy. This Official Statement of the American Thoracic Society was adopted by the ATS Board of Directors, March 1991. Am Rev Respir Dis. 1991;144:726-731.
155. McDermid RC, Bagshaw SM. Prolonging life and delaying death: the role of physicians in the context of limited intensive care resources. Philos Ethics Humanit Med. 2009;4:3.
156. Krumholz HM, Merrill AR, Schone EM, et al. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes. 2009;2:407-413.
157. Bernheim SM, Grady JN, Lin Z, et al. National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure: update on publicly reported outcomes measures based on the 2010 release. Circ Cardiovasc Qual Outcomes. 2010;3:459-467.
158. Bernheim SM, Spertus JA, Reid KJ, et al. Socioeconomic disparities in outcomes after acute myocardial infarction. Am Heart J. 2007;153:313-319. (Pubitemid 46096873)
159. Rahimi AR, Spertus JA, Reid KJ, et al. Financial barriers to health care and outcomes after acute myocardial infarction. JAMA. 2007;297:1063-1072. (Pubitemid 46425511)
160. Smolderen KG, Spertus JA, Reid KJ, et al. The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009;2:328-337.
161. Zamorano JL, Badano LP, Bruce C, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. J Am Soc Echocardiogr. 2011;24:937-965.
162. Messika-Zeitoun D, Serfaty JM, Brochet E, et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol. 2010;55:186-194.
163. Delgado V, Tops LF, Schuijf JD, et al. Successful deployment of a transcatheter aortic valve in bicuspid aortic stenosis: role of imaging with multislice computed tomography. Circ Cardiovasc Imaging. 2009;2:e12-e13.
164. Akhtar M, Tuzcu EM, Kapadia SR, et al. Aortic root morphology in patients undergoing percutaneous aortic valve replacement: evidence of aortic root remodeling. J Thorac Cardiovasc Surg. 2009;137:950-956.
165. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777-802. (Pubitemid 37391035)
166. Ng AC, Delgado V, van der Kley F, et al. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2- and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ Cardiovasc Imaging. 2010;3:94-102.
167. Janosi RA, Kahlert P, Plicht B, et al. Measurement of the aortic annulus size by real-time three-dimensional transesophageal echocardiography. Minim Invasive Ther Allied Technol. 2011;20:85-94.
168. Schoenhagen P, Tuzcu EM, Kapadia SR, et al. Three-dimensional imaging of the aortic valve and aortic root with computed tomography: new standards in an era of transcatheter valve repair/implantation. Eur Heart J. 2009;30:2079-2086.
169. Al Ali AM, Altwegg L, Horlick EM, et al. Prevention and management of transcatheter balloon-expandable aortic valve malposition. Catheter Cardiovasc Interv. 2008;72:573-578.
170. Schwartz JG, Neubauer AM, Fagan TE, et al. Potential role of three-dimensional rotational angiography and C-arm CT for valvular repair and implantation. Int J Cardiovasc Imaging. 2011;27:1205-1222.
171. Koos R, Altiok E, Mahnken AH, et al. Evaluation of aortic root for definition of prosthesis size by magnetic resonance imaging and cardiac computed tomography: implications for transcatheter aortic valve implantation. Int J Cardiol. 2011: published online before print February 9, 2011, doi:10.1016/ j.ijcard.2011.01.044. Accessed January 13, 2012.
172. Schoenhagen P, Numburi U, Halliburton SS, et al. Three-dimensional imaging in the context of minimally invasive and transcatheter cardiovascular interventions using multi-detector computed tomography: from pre-operative planning to intraoperative guidance. Eur Heart J. 2010;31:2727-2740.
173. Chenot F, Montant P, Goffinet C, et al. Evaluation of anatomic valve opening and leaflet morphology in aortic valve bioprosthesis by using multidetector CT: comparison with transthoracic echocardiography. Radiology. 2010;255:377-385.
174. Earls JP, Berman EL, Urban BA, et al. Prospectively gated transverse coronary CT angiography versus retrospectively gated helical technique: improved image quality and reduced radiation dose. Radiology. 2008;246:742-753.
175. Feuchtner G, Goetti R, Plass A, et al. Dual-step prospective ECG-triggered 128-slice dual-source CT for evaluation of coronary arteries and cardiac function without heart rate control: a technical note. Eur Radiol. 2010;20:2092-2099.
176. Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010;31:865-874.
177. Joshi SB, Mendoza DD, Steinberg DH, et al. Ultra-low-dose intra-arterial contrast injection for iliofemoral computed tomographic angiography. J Am Coll Cardiol Img. 2009;2:1404-1411.
178. Moss RR, Ivens E, Pasupati S, et al. Role of echocardiography in percutaneous aortic valve implantation. J Am Coll Cardiol Img. 2008;1:15-24. (Pubitemid 351445392)
179. Leipsic J, Gurvitch R, Labounty TM, et al. Multidetector computed tomography in transcatheter aortic valve implantation. J Am Coll Cardiol Img. 2011;4:416-429.
180. O'Brien B, Schoenhagen P, Kapadia SR, et al. Integration of 3D imaging data in the assessment of aortic stenosis: impact on classification of disease severity. Circ Cardiovasc Imaging. 2011;4:566-573.
181. Pontone G, Andreini D, Bartorelli AL, et al. Feasibility and accuracy of a comprehensive multidetector computed tomography acquisition for patients referred for balloon-expandable transcatheter aortic valve implantation. Am Heart J. 2011;161:1106-1113.
182. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726-732.
183. Tops LF, Wood DA, Delgado V, et al. Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. J Am Coll Cardiol Img. 2008;1:321-330. (Pubitemid 351681425)
184. Masson JB, Kovac J, Schuler G, et al. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. J Am Coll Cardiol Intv. 2009;2:811-820.
185. Delgado V, Ng AC, van de Veire NR, et al. Transcatheter aortic valve implantation: role of multi-detector row computed tomography to evaluate prosthesis positioning and deployment in relation to valve function. Eur Heart J. 2010;31:1114-1123.
186. Gurvitch R, Wood DA, Leipsic J, et al. Multislice computed tomography for prediction of optimal angiographic deployment projections during transcatheter aortic valve implantation. J Am Coll Cardiol Intv. 2010;3:1157-1165.
187. Kurra V, Kapadia SR, Tuzcu EM, et al. Pre-procedural imaging of aortic root orientation and dimensions: comparison between x-ray angiographic planar imaging and 3-dimensional multidetector row computed tomography. J Am Coll Cardiol Intv. 2010;3:105-113.
188. Jabbour A, Ismail TF, Moat N, et al. Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am Coll Cardiol. 2011;58:2165-2173.
189. Yucel EK, Anderson CM, Edelman RR, et al. AHA scientific statement. Magnetic resonance angiography: update on applications for extracranial arteries. Circulation. 1999;100:2284-2301.
190. Sherif MA, Abdel-Wahab M, Beurich HW, et al. Haemodynamic evaluation of aortic regurgitation after transcatheter aortic valve implantation using cardiovascular magnetic resonance. EuroIntervention. 2011;7:57-63.
191. Juluru K, Vogel-Claussen J, Macura KJ, et al. MR imaging in patients at risk for developing nephrogenic systemic fibrosis: protocols, practices, and imaging techniques to maximize patient safety. Radiographics. 2009;29:9-22.
192. Billings FT, Kodali SK, Shanewise JS. Transcatheter aortic valve implantation: anesthetic considerations. Anesth Analg. 2009;108:1453-1462.
193. Klein AA, Webb ST, Tsui S, et al. Transcatheter aortic valve insertion: anaesthetic implications of emerging new technology. Br J Anaesth. 2009;103:792-799.
194. Guinot PG, Depoix JP, Etchegoyen L, et al. Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth. 2010;24:752-761.
195. Burnakis TG, Berman DE. Hostility and hallucinations as a consequence of midazolam administration. DICP. 1989;23: 671-672. (Pubitemid 19231983)
196. Latsios G, Gerckens U, Buellesfeld L, et al. "Device landing zone" calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI. Catheter Cardiovasc Interv. 2010;76:431-439.
197. Fassl J, Seeberger MD, Augoustides JG. Transcatheter aortic valve implantation: is general anesthesia superior to conscious sedation?. J Cardiothorac Vasc Anesth. 2011;25:576-577.
198. Kurra V, Schoenhagen P, Roselli EE, et al. Prevalence of significant peripheral artery disease in patients evaluated for percutaneous aortic valve insertion: preprocedural assessment with multidetector computed tomography. J Thorac Cardiovasc Surg. 2009;137:1258-1264.
199. Sharp AS, Michev I, Maisano F, et al. A new technique for vascular access management in transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010;75:784-793.
200. Etienne PY, Papadatos S, El Khoury E, et al. Transaortic transcatheter aortic valve implantation with the Edwards SAPIEN valve: feasibility, technical considerations, and clinical advantages. Ann Thorac Surg. 2011;92:746-748.
201. Guarracino F, Cabrini L, Baldassarri R, et al. Non-invasive ventilation-aided transoesophageal echocardiography in high-risk patients: a pilot study. Eur J Echocardiogr. 2010;11:554-556.
202. Bartel T, Bonaros N, Muller L, et al. Intracardiac echocardiography: a new guiding tool for transcatheter aortic valve replacement. J Am Soc Echocardiogr. 2011;24:966-975.
203. Cahalan MK, Stewart W, Pearlman A, et al. American Society of Echocardiography and Society of Cardiovascular Anesthesiologists task force guidelines for training in perioperative echocardiography. J Am Soc Echocardiogr. 2002;15:647-652. (Pubitemid 46019428)
204. Al-Attar N, Himbert D, Vahanian A, et al. Severe intraprosthetic regurgitation by immobile leaflet after trans-catheter aortic valve implantation. Eur J Cardiothorac Surg. 2011;39:591-592.
205. Ussia GP, Sarkar K, Tamburino C. Aortic valve perforation during aortic valvuloplasty: identification and strategies for prevention. Catheter Cardiovasc Interv. 2011;77:876-880.
206. Ussia GP, Barbanti M, Ramondo A, et al. The valve-in-valve technique for treatment of aortic bioprosthesis malposition an analysis of incidence and 1-year clinical outcomes from the Italian CoreValve registry. J Am Coll Cardiol. 2011;57:1062-1068.
207. Sherif MA, Abdel-Wahab M, Stocker B, et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol. 2010;56:1623-1629.
208. Latib A, Michev I, Laborde JC, et al. Post-implantation repositioning of the CoreValve percutaneous aortic valve. J Am Coll Cardiol Intv. 2010;3:119-121.
209. Webb JG, Wood DA, Ye J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121:1848-1857.
210. Ruiz CE, Cohen H, Del Valle-Fernandez R, et al. Closure of prosthetic paravalvular leaks: a long way to go. Eur Heart J Suppl. 2010;12 Suppl E:E52-E62.
211. Schultz CJ, Moelker A, Piazza N, et al. Three dimensional evaluation of the aortic annulus using multislice computer tomography: are manufacturer's guidelines for sizing for percutaneous aortic valve replacement helpful?. Eur Heart J. 2010;31:849-856.
212. Babaliaros VC, Liff D, Chen EP, et al. Can balloon aortic valvuloplasty help determine appropriate transcatheter aortic valve size?. J Am Coll Cardiol Intv. 2008;1:580-586.
213. Witzke C, Don CW, Cubeddu RJ, et al. Impact of rapid ventricular pacing during percutaneous balloon aortic valvuloplasty in patients with critical aortic stenosis: should we be using it?. Catheter Cardiovasc Interv. 2010;75:444-452.
214. Gurvitch R, Tay EL, Wijesinghe N, et al. Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients. Catheter Cardiovasc Interv. 2011;78:977-984.
215. Nuis RJ, Van Mieghem NM, Van der Boon RM, et al. Effect of experience on results of transcatheter aortic valve implantation using a Medtronic CoreValve System. Am J Cardiol. 2011;107:1824-1829.
216. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755-763. (Pubitemid 47255993)
217. Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation. 2009;119:3009-3016.
218. Tommaso C, Bolman RM, Feldman T, et al. Multisociety expert consensus statement: operator & institutional requirements for transcatheter valve repair and replacement; part 1 TAVR. J Am Coll Cardiol. 2012. March 1 [E-pub ahead of print], doi: 10.1016/j.jacc.2012.02.016.
219. Himbert D, Roy D, Brecker S, et al. Tools & techniques: transcatheter aortic valve implantation: transfemoral approach. EuroIntervention. 2011;6:784-785.
220. Gurvitch R, Cheung A, Bedogni F, et al. Coronary obstruction following transcatheter aortic valve-in-valve implantation for failed surgical bioprostheses. Catheter Cardiovasc Interv. 2011;77:439-444.
221. Ussia GP, Scarabelli M, Mule M, et al. Postprocedural management of patients after transcatheter aortic valve implantation procedure with self-expanding bioprosthesis. Catheter Cardiovasc Interv. 2010;76:757-766.
222. Burkhoff D, O'Neill W, Brunckhorst C, et al. Feasibility study of the use of the TandemHeart percutaneous ventricular assist device for treatment of cardiogenic shock. Catheter Cardiovasc Interv. 2006;68:211-217. (Pubitemid 44167670)
223. Maganti MD, Rao V, Borger MA, et al. Predictors of low cardiac output syndrome after isolated aortic valve surgery. Circulation. 2005;112:I448-I452. (Pubitemid 41266713)
224. Suh WM, Witzke CF, Palacios IF. Suicide left ventricle following transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010;76:616-620.
225. Abdel-Wahab M, Zahn R, Horack M, et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart. 2011;97:899-906.
226. Himbert D, Brochet E, Serfaty JM, et al. Contained aortic root rupture after transcatheter aortic valve implantation. Eur Heart J. 2010;31:2995.
227. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg firstin- man study. Circulation. 2006;114:1616-1624. (Pubitemid 44547432)
228. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69-76. (Pubitemid 46970878)
229. Khawaja MZ, Rajani R, Cook A, et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation. 2011;123:951-960.
230. Haworth P, Behan M, Khawaja M, et al. Predictors for permanent pacing after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010;76:751-756.
231. Sinhal A, Altwegg L, Pasupati S, et al. Atrioventricular block after transcatheter balloon expandable aortic valve implantation. J Am Coll Cardiol Intv. 2008;1:305-309. (Pubitemid 351816793)
232. Tuzcu EM. Transcatheter aortic valve replacement malposition and embolization: innovation brings solutions also new challenges. Catheter Cardiovasc Interv. 2008;72:579-580.
233. Tay EL, Gurvitch R, Wijeysinghe N, et al. Outcome of patients after transcatheter aortic valve embolization. J Am Coll Cardiol Intv. 2011;4:228-234.
234. Aminian A, Lalmand J, El Nakadi B. Perforation of the descending thoracic aorta during transcatheter aortic valve implantation (TAVI): an unexpected and dramatic procedural complication. Catheter Cardiovasc Interv. 2011;77:1076-1078.
235. Sun JC, Davidson MJ, Lamy A, et al. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends. Lancet. 2009;374:565-576.
236. Clavel MA, Rodes-Cabau J, Dumont E, et al. Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography. J Am Coll Cardiol Img. 2011;4:1053-1062.
237. Clavel MA, Webb JG, Pibarot P, et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol. 2009;53:1883-1891.
238. Pibarot P, Dumesnil JG. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol. 2000;36:1131-1141.
239. Mohty D, Malouf JF, Girard SE, et al. Impact of prosthesis-patient mismatch on long-term survival in patients with small St Jude Medical mechanical prostheses in the aortic position. Circulation. 2006;113:420-426. (Pubitemid 43803204)
240. Blais C, Dumesnil JG, Baillot R, et al. Impact of valve prosthesis- patient mismatch on short-term mortality after aortic valve replacement. Circulation. 2003;108:983-988. (Pubitemid 37048229)
241. Gutierrez M, Rodes-Cabau J, Bagur R, et al. Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. Am Heart J. 2009;158:302-308.
242. Fuster V, Ryden LE, Cannom DS, et al. 2011 ACCF/AHA/ HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;57:e101-e198.
243. Morgenstern LB, Hemphill JC III, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108-2129.
244. Adams HP Jr., del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-1711. (Pubitemid 46691097)
245. Douglas PS, Garcia MJ, Haines DE, et al. ACCF/ASE/AHA/ ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 appropriate use criteria for echocardiography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2011;57:1126-1166.
246. Webb J, Cribier A. Percutaneous transarterial aortic valve implantation: what do we know? Eur Heart J. 2011;32:140-147.
247. Lutter G, Kuklinski D, Berg G, et al. Percutaneous aortic valve replacement: an experimental study. I. Studies on implantation. J Thorac Cardiovasc Surg. 2002;123:768-776. (Pubitemid 34535087)
248. Levi DS, Kusnezov N, Carman GP. Smart materials applications for pediatric cardiovascular devices. Pediatr Res. 2008;63:552-558. (Pubitemid 351572226)
249. Dainese L, Fusari M, Trabattoni P, et al. Redo in aortic homograft replacement: transcatheter aortic valve as a valid alternative to surgical replacement. J Thorac Cardiovasc Surg. 2010;139:1656-1657.
250. de Weger A, Ewe SH, Delgado V, et al. First-in-man implantation of a trans-catheter aortic valve in a mitral annuloplasty ring: novel treatment modality for failed mitral valve repair. Eur J Cardiothorac Surg. 2011;39:1054-1056.
251. Kelpis TG, Mezilis NE, Ninios VN, et al. Minimally invasive transapical aortic valve-in-a-valve implantation for severe aortic regurgitation in a degenerated stentless bioprosthesis. J Thorac Cardiovasc Surg. 2009;138:1018-1020.
252. Maroto LC, Rodriguez JE, Cobiella J, et al. Transapical off-pump aortic valve-in-a-valve implantation in two elderly patients with a degenerated porcine bioprosthesis. Eur J Cardiothorac Surg. 2010;37:738-740.
253. Rodes-Cabau J, Dumont E, Doyle D, et al. Transcatheter valve-in- valve implantation for the treatment of stentless aortic valve dysfunction. J Thorac Cardiovasc Surg. 2010;140:246-248.
254. Walther T, Kempfert J, Borger MA, et al. Human minimally invasive off-pump valve-in-a-valve implantation. Ann Thorac Surg. 2008;85:1072-1073. (Pubitemid 351260026)
255. Mack MJ. Coronary obstruction following transcatheter aortic valve-in-valve implantation for failed surgical bioprostheses. Catheter Cardiovasc Interv. 2011;77:445-446.
256. Wijesinghe N, Ye J, Rodes-Cabau J, et al. Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis. J Am Coll Cardiol Intv. 2010;3:1122-1125.
257. Chiam PT, Chao VT, Tan SY, et al. Percutaneous transcatheter heart valve implantation in a bicuspid aortic valve. J Am Coll Cardiol Intv. 2010;3:559-561.
258. Ivers NM, Taljaard M, Dixon S, et al. Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8. BMJ. 2011;343:d5886.
259. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1-e34.
260. Rios LP, Ye C, Thabane L. Association between framing of the research question using the PICOT format and reporting quality of randomized controlled trials. BMC Med Res Methodol. 2010;10:11.